Navigation Links
Jeffrey Zucker of Worldwide Clinical Trials to Present at SCOPE 2016

MIAMI, February 11, 2016 /PRNewswire/ --

Jeffrey Zucker, vice president of Feasibility and Recruitment Optimization at Worldwide Clinical Trials, will present at this year's Summit for Clinical Operations Executives (SCOPE), being held Feb. 23-25 at the Hyatt Regency in Miami, FL. Zucker will discuss how sponsors can rebuild and enhance site partnerships to optimize study execution, supporting SCOPE's "Improving Site Study Activation and Performance" portion of the conference. His presentation will take place on Thursday, Feb. 25 at 11:05 a.m.

In addition to Zucker's presentation, experts from the Worldwide Clinical Trials team will also be on-hand at the company's booth (#311) to discuss the individual drug development challenges of SCOPE attendees, as well as their concerns and needs across a range of therapeutic areas, including neuroscience, cardiovascular disease, inflammatory disorders, and rare disease.

"The strategic balance of science, medicine and operations provides the foundation for successful execution of clinical trials," explains Zucker, who has more than 20 years of experience in clinical research operations. "While there are many challenges in trial planning and execution, during my presentation at SCOPE, I will explore how the relationship between the sponsor and the clinical trial site can have a significant impact on the efficiency and overall success of a clinical trial. From trial start-up and recruitment through implementation, I will offer strategies for establishing and maintaining key relationships, while defining the impact of a strong partnership."

The seventh annual SCOPE Summit will offer three days of discussions, conferences and workshops covering all aspects of clinical trial planning and management. To schedule an appointment with a Worldwide expert at SCOPE, visit . For further information about SCOPE, visit

About Worldwide Clinical Trials  

Worldwide Clinical Trials provides full-service drug development services to the pharmaceutical and biotechnology industries from Early Phase and Bioanalytical Sciences through Phase II and III trials to Peri-Approval studies. We believe successful drug development strategically balances science, medicine, operations and commercial intelligence. We approach every Phase I-IV drug development program as unique. Our mission is to foster the development of life changing medicines by integrating innovative methodology, rigorous science and efficient technology. For more information, visit

SOURCE Worldwide Clinical Trials
Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. Sorrento Expands its Executive Management Team with Appointment of Dr. Jeffrey Su as Chief Operating Officer to Lead its in-house Bioprocess and Manufacturing Operations
2. Halozyme Appoints Jeffrey W. Henderson To Board
3. Landauer, Inc. Appoints Jeffrey Bailey As Independent Director
4. Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors
5. Jeffrey W. Ubben, CEO Of ValueAct Capital, Appointed To The Board Of Valeant Pharmaceuticals
6. Blueprint Medicines Appoints Jeffrey Albers as Chief Executive Officer
7. Texas Childrens Hospital establishes the Jeffrey Modell Diagnostic & Research Center with a donation from the Jeffrey Modell Foundation
8. Worldwide Clinical Trials Expert to Present at Evidence EU 2016
9. Radiology Oncology Surgical Robots: Market Shares, Strategies, and Forecasts, Worldwide, 2016-2022
10. Merck, Pfizer and AstraZeneca Emerge as Leaders in the 2016 Indegene Worldwide Digital Savvy HCP Study
11. California Institute for Biomedical Research (Calibr) enters worldwide strategic collaboration with Pfizer Inc.
Post Your Comments:
(Date:8/8/2020)... ... ... By now, we all know that there are two good ways to fight COVID-19. One ... warm water. , The other is to disinfect high touch surfaces, according to the CDC. ... remote controls might come to mind. , But what about your car? , While you ...
(Date:8/7/2020)... ... ... Death Midwifery returns death to its sacred place in the beauty, mystery and ... conscious dying experience; guides loved ones in after-death care of the body; and empowers ... offer compassionate support to individuals and their families from terminal diagnosis to final disposition. ...
(Date:8/5/2020)... ... August 04, 2020 , ... In an informal poll of 150 fans, ... for a refreshed Minnesota Twins “Minnie and Paul” logo that is more racially and ... That was well before the civil rights movement in the United States. The Minnesota ...
Breaking Medicine Technology:
(Date:8/5/2020)... ... August 05, 2020 , ... AdventHealth Carrollwood has partnered with Bayshore Christian School ... Monday, August 12, 2020. AdventHealth provided the school with key strategies and implementation plans ... setting. , “We are taking extra steps in our hospital and in our ...
(Date:8/5/2020)... ... , ... Hypoglycemia (low blood glucose levels) in hospitalized patients ... even death. A researcher at the VA Maryland Health Care System, conducted the ... the use of continuous glucose monitoring devices can prevent hypoglycemia in inpatients on ...
(Date:8/5/2020)... , ... August 05, 2020 , ... ... animal health industry, as president of the largest veterinarian-owned purchasing Cooperative in the ... ANIMALE in various roles where she gained extensive knowledge and experience in the ...
(Date:8/5/2020)... ... , ... Today, YPO Africa , a global leadership community of chief ... announced that they have entered into a unique bilateral alliance. The key aim of ... in their African impact efforts, with an initial focus on YPO’s Lead COVID-19 ...
(Date:8/5/2020)... (PRWEB) , ... August 04, 2020 , ... ... adults living with memory impairment, has announced the Best Memory Care Facilities in ... to experts, facility features and amenities. , According to the Alzheimer’s ...
Breaking Medicine News(10 mins):